Daniel K Spiegelman - Net Worth and Insider Trading

Over the past 18 months, Daniel K Spiegelman made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 4,172,336 shares made by Novo Holdings A/s ,

In summary, during the past 3 months, insiders sold 0 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,172,336 shares.

Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel K Spiegelman made 1 insider transaction in Myriad Genetics Inc (MYGN) with a net sale of 7,576. Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 257,844 shares made by Paul J Diaz , a net sale of 60,000 shares made by Richard Bryan Riggsbee , and a net sale of 46,012 shares made by Reitan Colleen F .

In summary, during the past 3 months, insiders sold 42,100 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 42,100 shares. During the past 18 months, 408,770 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 408,770 shares.

Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel K Spiegelman made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 153,000 shares made by Jean Jacques Bienaime , a net sale of 92,066 shares made by George Eric Davis , and a net sale of 14,000 shares made by Jeffrey Robert Ajer .

In summary, during the past 3 months, insiders sold 5,278 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 5,278 shares. During the past 18 months, 325,045 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 325,045 shares.

Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Relypsa Inc (RLYP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relypsa Inc (RLYP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Relypsa Inc (RLYP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc (ANTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc (ANTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anthera Pharmaceuticals Inc (ANTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel K Spiegelman made no insider transaction in Omeros Corp (OMER). Other recent insider transactions involving Omeros Corp (OMER) include a net purchase of 15,000 shares made by Demopulos Gregory A Md , and a net purchase of 10,000 shares made by Demopulos Peter A Md .

In summary, during the past 3 months, insiders sold 0 shares of Omeros Corp (OMER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Omeros Corp (OMER) were sold and 25,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Omeros Corp (OMER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel K Spiegelman made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Jiya Acquisition Corp (JYAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiya Acquisition Corp (JYAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiya Acquisition Corp (JYAC)'s detailed insider trading history can be found in Insider Trading Tracker table.